Skip to content

HONNEUR MEDIC

Active
Private limited companyfounded 20233 yrs activeGemeneweidestraat 107, 8000 Brugge, BelgiumKBO/BCE: BE 0802.791.695
Summary

The computed 12-month bankruptcy probability of HONNEUR MEDIC is 2.5% (moderate). The 2025 annual accounts show equity of €160k and a net result of €99k. Equity is growing by ~111.2% per year across the filed fiscal years. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
79 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency92▼-8
Growth78=
Track record94
Bankruptcy probability, 12 months
2.5% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity ample (current ratio 3.07 against 6.06 in 2024; short-term debt: 32.6% and cash: 55.2% of total assets), and 32.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
67.4%
Return on assets
41.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-03-2026, 134 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
134 d early
2024
3 d early
2023
77 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€160k▲ 165%
2024 · €60k
2023: €26k 2024: €60k
2023 → 2025
Total assets
€237k▲ 228%
2024 · €72k
2023: €31k 2024: €72k
2023 → 2025
Net result
€99k▲ 186%
2024 · €35k
2023: €21k 2024: €35k
2023 → 2025
Working capital
€160k▲ 165%
2024 · €60k
2023: €26k 2024: €60k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€26k-€60k▲ 136%€160k▲ 165%
Operating result€26k-€44k▲ 71.0%€128k▲ 188%
Net result€21k-€35k▲ 69.6%€99k▲ 186%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2023: €26k€26kNet result 2023: €21k€21kOperating result 2024: €44k€44kNet result 2024: €35k€35kOperating result 2025: €128k€128kNet result 2025: €99k€99k202320242025€0€50k€100k€150kOperating result 2023: €26k€26kNet result 2023: €21k€21kOperating result 2024: €44k€44kNet result 2024: €35k€35kOperating result 2025: €128k€128kNet result 2025: €99k€99k202320242025
The operating result has risen two years in a row; 2025 is 188% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €237k
Equity €160k ▲ 165%
Debt €77k ▲ 549%
Debt's share of the balance-sheet total rises from 16.5% to 32.6%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
Current ratio
3.07
2024 · 6.06
Debt to equity
0.48
2024 · 0.20
ROE
62.2%
2024 · 57.7%
ROA
41.9%
2024 · 48.2%
Debt ≤ 1 year
€77k
2024 · €12k
Income taxes
€29k
2024 · €10k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 33 lines
Balance sheet Code20242025
Assets
Total assets20/58€72k€237k
Current assets29/58€72k€237k
Amounts receivable within one year40/41€10k€106k
Trade receivables40€10k€105k
Other amounts receivable41€154€605
Cash at bank and in hand54/58€62k€131k
Deferred charges and accrued income490/1€490€367
Equity and liabilities
Total equity and liabilities10/49€72k€237k
Equity10/15€60k€160k
Contributions10/11€5k€5k=
Reserves13€55k€155k
Distributable reserves133€55k€155k
Amounts payable17/49€12k€77k
Amounts payable within one year42/48€12k€77k
Trade debts44€1k€4k
Suppliers440/4€1k€4k
Taxes, remuneration and social security45€10k€38k
Taxes450/3€10k€38k
Other amounts payable47/48-€35k
Income statement Code20242025
Other operating charges640/8€126€128
Gross operating margin9900€45k€128k
Operating profit (loss)9901€44k€128k
Financial income75/76B€182€21
Recurring financial income75€182€21
Financial charges65/66B€70€75
Recurring financial charges65€70€75
Profit (loss) for the period before taxes9903€44k€128k
Income taxes67/77€10k€29k
Profit (loss) for the period9904€35k€99k
Profit (loss) for the period to be appropriated9905€35k€99k
Appropriation of the result
Profit (loss) to be appropriated9906€35k€99k
Transfer to equity691/2€35k€99k
To other reserves6921€35k€99k

The notes to these accounts (2 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
19-03
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2023net €99k ▲186%
Operating result €128k, net result €99k, both a record.
31-12
Financial Equity above €150kEq €160k ▲165%
3 profitable years in a row build equity to €160k.
28-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
15-05
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brugge · 1 establishment unit since 2023
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Gemeneweidestraat 1078000 Brugge
Ground area
25.7 ha
Building footprint
1,684 m²
Volume, LiDAR
1,282 m³
2 parcels, Flanders · tallest building 15.0 m. Linked by address, not a title deed.
1 establishment unit
HONNEUR MEDIC
Ruddershove 10, 8000 BruggeSpecialist medical practice
since 20232.346.827.502
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31808M0253/00M002 Flanders 25.5 ha 1 · 1,520 m² 15.0 m
31014A0204/00K002 Flanders 1,852 m² 1 · 164 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded15-06-2023
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.